Introduced:
Sep 4, 2025
Policy Area:
Health
Congress.gov:
Bill Statistics
3
Actions
1
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text
AI Summary
AI Summary
No AI Summary Available
Click the button above to generate an AI-powered summary of this bill using Claude.
The summary will analyze the bill's key provisions, impact, and implementation details.
Error generating summary
Latest Action
Sep 4, 2025
Referred to the House Committee on Energy and Commerce.
Actions (3)
Referred to the House Committee on Energy and Commerce.
Type: IntroReferral
| Source: House floor actions
| Code: H11100
Sep 4, 2025
Introduced in House
Type: IntroReferral
| Source: Library of Congress
| Code: Intro-H
Sep 4, 2025
Introduced in House
Type: IntroReferral
| Source: Library of Congress
| Code: 1000
Sep 4, 2025
Subjects (1)
Health
(Policy Area)
Cosponsors (1)
(R-TN)
Sep 4, 2025
Sep 4, 2025
Full Bill Text
Length: 9,035 characters
Version: Introduced in House
Version Date: Sep 4, 2025
Last Updated: Nov 13, 2025 6:32 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5162 Introduced in House
(IH) ]
<DOC>
119th CONGRESS
1st Session
H. R. 5162
To authorize the Secretary of Health and Human Services, acting through
the Director of the Centers for Disease Control and Prevention, to make
grants to States to increase awareness and education for colorectal
cancer and improve early detection of colorectal cancer in young
individuals, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
September 4, 2025
Ms. Stevens (for herself and Mr. Burchett) introduced the following
bill; which was referred to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To authorize the Secretary of Health and Human Services, acting through
the Director of the Centers for Disease Control and Prevention, to make
grants to States to increase awareness and education for colorectal
cancer and improve early detection of colorectal cancer in young
individuals, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
[From the U.S. Government Publishing Office]
[H.R. 5162 Introduced in House
(IH) ]
<DOC>
119th CONGRESS
1st Session
H. R. 5162
To authorize the Secretary of Health and Human Services, acting through
the Director of the Centers for Disease Control and Prevention, to make
grants to States to increase awareness and education for colorectal
cancer and improve early detection of colorectal cancer in young
individuals, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
September 4, 2025
Ms. Stevens (for herself and Mr. Burchett) introduced the following
bill; which was referred to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To authorize the Secretary of Health and Human Services, acting through
the Director of the Centers for Disease Control and Prevention, to make
grants to States to increase awareness and education for colorectal
cancer and improve early detection of colorectal cancer in young
individuals, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1.
This Act may be cited as the ``Colorectal Cancer Early Detection
Act''.
SEC. 2.
Congress finds the following:
(1) In the United States, colorectal cancer is the third
leading cause of cancer-related deaths in men and the fourth
leading cause in women. Colorectal cancer is the second most
common cause of cancer deaths when numbers for men and women
are combined.
(2) In the United States, there were over 141,000 new
colorectal cancer cases and 52,000 new colorectal cancer deaths
reported in 2021. It is estimated that there will be over
154,270 new cases of colorectal cancer and 52,900 cases of
colorectal cancer deaths in 2025.
(3) Colorectal cancer rates have been increasing in young
patients. About 1 in 5 cases of colorectal cancer were in
individuals age 54 and younger.
(4) In early 2023, it was reported that about 20 percent of
diagnoses of colorectal cancer were among patients under the
age of 55. Additionally, half of all early-onset colorectal
cancer cases are diagnosed in individuals under 45 years old.
(5) Colorectal cancer cases among individuals ages 20 to 39
are expected to increase by 90 percent by 2030. Additionally,
colorectal cancer is projected to be the leading cause of
cancer-related deaths for individuals under 50 years of age by
2030.
SEC. 3.
AND EARLY DETECTION AMONG YOUNG INDIVIDUALS.
(a)
(a)
=== Definitions. ===
-In this section:
(1) State.--The term ``State'' means each of the several
States, the District of Columbia, and any territory or
possession of the United States.
(2) Young individual.--The term ``young individual'' means
an individual who has not attained the age of 45.
(b) In General.--The Secretary of Health and Human Services, acting
through the Director of the Centers for Disease Control and Prevention,
(in this section referred to as the ``Secretary'') may make grants to
States, on a competitive basis, for the purpose of increasing awareness
and education for colorectal cancer and early detection of colorectal
cancer in young individuals.
(c) Application.--To be eligible for a grant under this section, a
State shall submit to the Secretary an application at such time, in
such manner, and containing such information as the Secretary may
require, including a detailed description of the State's plan to
implement the grant. Such description shall include how the State will
use the grant to--
(1) conduct outreach and education regarding incidence of
colorectal cancer and risk factors, with an emphasis on--
(A) young individuals with an increased risk or
high risk for colorectal cancer, including--
(i) young individuals with a family history
of colorectal cancer or advanced adenomatous
polyps;
(ii) young individuals with a personal
history of inflammatory bowel disease (commonly
known as ``IBD''), including ulcerative colitis
and Crohn's disease of the colon;
(iii) young individuals with an inherited
syndrome, including Lynch syndrome, familial
adenomatous polyposis, and other inherited
syndromes linked to colorectal cancer;
(iv) young individuals with signs and
symptoms of colorectal cancer, particularly
rectal bleeding and iron deficiency anemia; and
(v) other young individuals with risk
factors (such as risk factors identified by
nationally recognized guidelines) that put such
individuals at increased risk for colorectal
cancer, as determined by the Secretary; and
(B) individuals in underserved and rural areas,
individuals who identify as American Indian, Alaska
Native, or African American, and individuals with type
2 diabetes, for the purposes of--
(i) identifying individuals who are at
increased risk or high risk for colorectal
cancer (including young individuals described
in clauses
(i) through
(v) of subparagraph
(A) )
and would benefit from early detection before
age 45; and
(ii) providing education to initiate early
detection at age 45 for individuals who are not
at increased risk or high risk for colorectal
cancer;
(2) partner with hospitals, clinics, Tribal organizations
(as defined in
section 4 of the Indian Self-Determination and
Education Assistance Act), nonprofit organizations,
institutions of higher education, colorectal cancer prevention
and control programs, and other relevant entities and programs
to enhance outreach, education, and early detection efforts
with respect to colorectal cancer in young individuals; and
(3) conduct activities to increase awareness and education
for colorectal cancer and improve early detection of colorectal
cancer in young individuals, including navigation and program
evaluation.
Education Assistance Act), nonprofit organizations,
institutions of higher education, colorectal cancer prevention
and control programs, and other relevant entities and programs
to enhance outreach, education, and early detection efforts
with respect to colorectal cancer in young individuals; and
(3) conduct activities to increase awareness and education
for colorectal cancer and improve early detection of colorectal
cancer in young individuals, including navigation and program
evaluation.
(d) Use of Funds.--A grant under this section may be used for any
of the following:
(1) To support early detection and diagnostic testing for
colorectal cancer in young individuals deemed to be at
increased risk or high risk of colorectal cancer as part of a
preventive health measure strategy.
(2) To provide appropriate referrals for medical treatment,
including genetic testing and counseling of such young
individuals, and to ensure, to the extent practicable, the
provision of appropriate follow-up and surveillance services.
(3) To develop and implement a public awareness and
education campaign for the early detection, signs and symptoms,
risk factors, and control management of colorectal cancer,
specifically in young individuals.
(4) To conduct education and outreach to health
professionals (including allied health professionals) on
conducting and interpreting colorectal cancer screening and
diagnostic tests and the latest advancements in the early
detection of colorectal cancer, with a focus on symptoms,
genetic risk factors, family history, and care for young
individuals.
(5) To establish mechanisms through which the States can
monitor the quality of screening and diagnostic procedures for
colorectal cancer among young individuals, including the
interpretation of such procedures.
(6) To conduct surveillance to help determine other risk
factors for colorectal cancer.
(7) To develop strategies to capture and assess family
history and genetic predispositions to colorectal cancer in
young individuals.
(8) To establish patient navigation support to assist
individuals through the process of screening, particularly
those at increased risk or high risk for colorectal cancer.
(9) To design clinician decision support tools based on
clinical practice guidelines for early detection of colorectal
cancer in young individuals.
(10) To monitor and evaluate activities conducted under
paragraphs
(1) through
(9) to determine the effectiveness of
such activities to inform continuous improvement of such
activities.
(e) Grant Period.--A grant under this section shall be for a period
of 5 years, and may be renewed at the discretion of the Secretary.
(f) Return of Unspent Grant Funds.--Each State that receives a
grant under this section shall return, not later than 6 months after
the date on which the period of such grant ends, any grant funds that
were not expended by such State during the grant period.
(g) Report.--Not later than 5 years after receiving a grant under
this section (including a renewal of a grant), a State shall submit to
the Secretary a report describing how the State used such grant.
<all>
institutions of higher education, colorectal cancer prevention
and control programs, and other relevant entities and programs
to enhance outreach, education, and early detection efforts
with respect to colorectal cancer in young individuals; and
(3) conduct activities to increase awareness and education
for colorectal cancer and improve early detection of colorectal
cancer in young individuals, including navigation and program
evaluation.
(d) Use of Funds.--A grant under this section may be used for any
of the following:
(1) To support early detection and diagnostic testing for
colorectal cancer in young individuals deemed to be at
increased risk or high risk of colorectal cancer as part of a
preventive health measure strategy.
(2) To provide appropriate referrals for medical treatment,
including genetic testing and counseling of such young
individuals, and to ensure, to the extent practicable, the
provision of appropriate follow-up and surveillance services.
(3) To develop and implement a public awareness and
education campaign for the early detection, signs and symptoms,
risk factors, and control management of colorectal cancer,
specifically in young individuals.
(4) To conduct education and outreach to health
professionals (including allied health professionals) on
conducting and interpreting colorectal cancer screening and
diagnostic tests and the latest advancements in the early
detection of colorectal cancer, with a focus on symptoms,
genetic risk factors, family history, and care for young
individuals.
(5) To establish mechanisms through which the States can
monitor the quality of screening and diagnostic procedures for
colorectal cancer among young individuals, including the
interpretation of such procedures.
(6) To conduct surveillance to help determine other risk
factors for colorectal cancer.
(7) To develop strategies to capture and assess family
history and genetic predispositions to colorectal cancer in
young individuals.
(8) To establish patient navigation support to assist
individuals through the process of screening, particularly
those at increased risk or high risk for colorectal cancer.
(9) To design clinician decision support tools based on
clinical practice guidelines for early detection of colorectal
cancer in young individuals.
(10) To monitor and evaluate activities conducted under
paragraphs
(1) through
(9) to determine the effectiveness of
such activities to inform continuous improvement of such
activities.
(e) Grant Period.--A grant under this section shall be for a period
of 5 years, and may be renewed at the discretion of the Secretary.
(f) Return of Unspent Grant Funds.--Each State that receives a
grant under this section shall return, not later than 6 months after
the date on which the period of such grant ends, any grant funds that
were not expended by such State during the grant period.
(g) Report.--Not later than 5 years after receiving a grant under
this section (including a renewal of a grant), a State shall submit to
the Secretary a report describing how the State used such grant.
<all>